Body integrity dysphoria

Body Integrity Dysphoria (BID)[edit | edit source]

A therapy session, an essential part of managing psychological conditions like BID.

Body Integrity Dysphoria (BID), also known as body integrity identity disorder, amputee identity disorder, and xenomelia (formerly apotemnophilia), is a psychological disorder characterized by a persistent desire to be disabled or a profound discomfort with being able-bodied. This condition typically begins in early adolescence and can lead to harmful consequences if not managed properly.

Terminology[edit | edit source]

BID has been known by various terms over the years, reflecting the evolving understanding of the condition. The term "transabled" is sometimes used by individuals with BID to describe themselves.

Symptoms and Manifestations[edit | edit source]

Symptoms of BID include:

Intense and persistent desire to become disabled, often focusing on limb amputation or paralysis
Discomfort or distress with one's able-bodied status
Emotional and psychological distress impacting daily functioning

Related Conditions[edit | edit source]

BID appears to be related to conditions like somatoparaphrenia, a disorder involving the denial of ownership of parts of one’s body.

Management and Treatment[edit | edit source]

Currently, there is no standard treatment for BID, but approaches may include:

Psychological counseling and therapy
Cognitive-behavioral therapy (CBT)
Medication for associated symptoms like depression or anxiety

Ethical and Social Considerations[edit | edit source]

BID raises various ethical, medical, and social considerations, particularly regarding the desire for elective disability and the support systems available for individuals with BID.

External Links[edit | edit source]

Body integrity dysphoria Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.